Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397)
11/2010
11/04/2010WO2010125811A1 Carbinol compound having heterocyclic linker
11/04/2010WO2010125350A1 Treatment or prophylaxis of proliferative conditions
11/04/2010WO2010125136A1 Benzenesulfonanilide compounds suitable for treating disorders that respond to modulation of the serotonin 5-ht6 receptor
11/04/2010WO2010125135A1 Benzenesulfonanilide compounds suitable for treating disorders that respond to modulation of the serotonin 5-ht6 receptor
11/04/2010WO2010125103A1 Diketopiperazine derivatives as p2x7 modulators
11/04/2010WO2010124619A1 1,2,3-3h pyridine heterocyclic compounds, their agricultural compositions, their use and their preparation methods
11/04/2010WO2010081625A3 Organic black pigments and their preparation
11/04/2010WO2010068863A3 Pyrimidine compounds and methods of making and using same
11/04/2010WO2009090548A3 3-azabicyclo [3.1.0] hexane derivatives as vanilloid receptor ligands
11/04/2010US20100281584 Novel systemic insecticide
11/04/2010US20100280091 Tri-substituted 2-benzhydryl-5-benzylamino-tetrahydro-pyran-4-ol and 6-benzhydryl-4-benzylamino-tetrahydro-pyran-3-ol analogues, and novel 3,6-disbustituted pyran derivatives
11/04/2010US20100280076 Derivatives of dioxan-2-alkyl carbamates, preparation thereof and application thereof in therapeutics
11/04/2010US20100280074 Ccr9 inhibitors and methods of use thereof
11/04/2010US20100280072 2-'4-(hydroxymethyl-phenylamino) -piperidine-1-yl!-n- (9h-carbazol-3yl) - acetamine derivatives and related compounds as neuropeptide y5 (npy5) ligands for the treatment of obesity
11/04/2010US20100280042 Quinazoline derivatives for the treatment of tumours
11/04/2010US20100280033 Pyrazole Derivatives
11/04/2010US20100280014 N-phenyl- (piperazinyl or homopiperazinyl)-benzenesulfonamide or benzenesulfonyl-phenl-(piperazine or homopiperazine) compounds suitable for treating disorders that respond to modulation of the serotonin 5-ht6 receptor
11/04/2010US20100280009 3,4-substituted pyrrolidine beta-secretase inhibitors for the treatment of alzheimer's disease
11/04/2010US20100279990 Antiproliferative compounds, compositions and methods of use
11/04/2010US20100279872 4-phenylpyrane-3,5-diones, 4-phenylthiopyrane-3,5-diones and 2-phenylcyclohexane-1,3,5-triones as herbicides
11/04/2010US20100279868 Novel herbicides
11/04/2010US20100279364 CCI-779 derivatives and methods of making same
11/04/2010US20100279340 Imaging agents for protein misfolding
11/04/2010US20100278811 Vasculostatic agents and methods of use thereof
11/04/2010CA2760526A1 Antimicrobial agents
11/04/2010CA2760031A1 Acetone solvate crystals of trityl olmesartan medoxomil
11/04/2010CA2759883A1 Treatment or prophylaxis of proliferative conditions
11/04/2010CA2759859A1 Carbinol compound having heterocyclic linker
11/04/2010CA2759494A1 Benzenesulfonanilide compounds suitable for treating disorders that respond to modulation of the serotonin 5-ht6 receptor
11/04/2010CA2759491A1 Benzenesulfonanilide compounds suitable for treating disorders that respond to modulation of the serotonin 5-ht6 receptor
11/04/2010CA2759163A1 Method for producing olmesartan medoxomil
11/04/2010CA2757761A1 Sulfamoyl benzoic acid derivatives as trpm8 antagonists
11/03/2010EP2246348A1 Coupling reactions useful in the preparation of (1h-tetrazol-5-yl)-biphenyl derivatives
11/03/2010EP2246345A1 Biphenyl derivatives having beta2 adrenergic receptor agonist and muscarinic receptor antagonist activity
11/03/2010EP2246344A1 Pyrimidine compounds and medicinal composition thereof
11/03/2010EP2246333A1 Indazole, benzisoxazole, and benzisothiazole kinase inhibitors
11/03/2010EP2246329A1 4(1H)-pyridinone derivatives and their use as antimalaria agents
11/03/2010EP2245027A1 Hepatitis c virus inhibitors
11/03/2010EP2245008A1 Method for the preparation of atorvastatin and intermediates used therein
11/03/2010EP2029572B1 Organic compounds
11/03/2010EP2001855B1 Benzimidazole derivatives and their use for modulating the gabaa receptor complex
11/03/2010EP1963260B1 Process for the production of ezetimibe and intermediates used in this process
11/03/2010EP1863477B1 3,4-substituted pyrrolidine derivatives for the treatment of hypertension
11/03/2010EP1805155B1 Thrombopoietin activity modulating compounds and methods
11/03/2010EP1641782B1 Hydroxycarbonylphenyl substituted 4-(aminomethyl)-piperidine benzamides as 5ht4-antagonists
11/03/2010EP1485093B1 Di-aryl substituted tetrazole modulators of metabotropic glutamate receptor-5
11/03/2010EP1220838B1 1-aziridino-1-hydroxyiminomethyl-derivatives, method for the production thereof and medicaments containing said compounds
11/03/2010CN1812812B Serum cholesterol lowering agnet or preventive or therapeutic agent for atherosclerosis
11/03/2010CN101878199A 1,2-disubstituted-4-benzylamino-pyrrolidine derivatives as cetp inhibitors useful for the treatment of diseases such as hyperli pidemia or arteriosclerosis
11/03/2010CN101875961A Diaryl and arylheteroaryl urea derivatives as modulators of the 5-HT2A serotonin receptor useful for the prophylaxis and treatment of disorders related therto
11/03/2010CN101875654A Process for producing 3-acylaminobenzofuran-2-carboxylic acid derivative
11/03/2010CN101875653A Preparation and application of 1,2,3-3H pyridine-heterocyclic compound
11/02/2010US7825265 di-aromatic compounds for treatment and prevention of diseases and disorders related to estrogen receptors; 2-fluoro-1-methoxy-4-(1-phenyl-cyclohexyl)-benzene
11/02/2010US7825255 Adenosine receptor selective modulators
11/02/2010US7825155 Oxindole derivative as feeding control agent
11/02/2010US7825152 Organic compounds and their uses
11/02/2010US7825141 Epothilone derivatives
11/02/2010US7825140 3,4-disubstituted 1H-pyrazole compounds and their use as cyclin dependent kinase and glycogen synthase kinase-3 modulators
11/02/2010US7825128 such as N-(ethoxycarbonyl)-S-(4-{[4-{[(R)-2-hydroxy-1-methylethyl]amino}-5-(2-thienyl)pyrimidine-2-yl]amino}phenyl)-S-methylsulfoximide, used for the treatment of breast cancer and rheumatoid arthritis
11/02/2010US7825109 Compound capable of binding S1P receptor and pharmaceutical use thereof
11/02/2010CA2389681C Npy y5 antagonist
10/2010
10/28/2010WO2010124201A2 Compositions and methods for treatment of cardiovascular disease
10/28/2010WO2010124121A1 Heteroaromatic and aromatic piperazinyl azetidinyl amides as monoacylglycerol lipase inhibitor
10/28/2010WO2010124119A1 Azetidinyl diamides as monoacylglycerol lipase inhibitors
10/28/2010WO2010124114A1 Azetidinyl diamides as monoacylglycerol lipase inhibitors
10/28/2010WO2010124112A1 Azetidinyl diamides as monoacylglycerol lipase inhibitors
10/28/2010WO2010124108A1 Azetidinyl diamides as monoacylglycerol lipase inhibitors
10/28/2010WO2010124086A1 Azetidinyl diamides as monoacylglycerol lipase inhibitors
10/28/2010WO2010123078A1 Method for predicting therapeutic effect of chemotherapy on renal cell cancer
10/28/2010WO2010123017A1 Tetrazole compound
10/28/2010WO2010123016A1 Carboxylic acid compound
10/28/2010WO2010122980A1 Novel thyroid hormone β receptor agonist
10/28/2010WO2010122927A1 Pharmaceutical agent for prevention or treatment of retarded nerve regeneration induced by diabetes
10/28/2010WO2010122669A1 Novel compound amycolamicin, method for production thereof, and use thereof
10/28/2010WO2010122082A1 Heterocyclic antiviral compounds
10/28/2010WO2010121918A1 Proline derivatives as cathepsin inhibitors
10/28/2010WO2010093849A3 Phenylalanine amide derivatives useful for treating insulin-related diseases and conditions
10/28/2010WO2010077976A3 Prokineticin receptor antagonists and uses thereof
10/28/2010WO2009118765A3 Novel monoamine re-uptake inhibitor
10/28/2010US20100274027 Organic compounds
10/28/2010US20100273849 Metalloproteinase Inhibitors
10/28/2010US20100273824 Substituted 1,3-dioxanes and their uses
10/28/2010US20100273794 Benzimidazolone Compounds Having 5-HT4 Receptor Agonistic Activity
10/28/2010US20100273764 Inhibitors of pi3 kinase and/or mtor
10/28/2010US20100273757 Pyrazine derivatives useful as adenosine receptor antagonists
10/28/2010US20100273193 Triacetone Triperoxide and Diacetone Diperoxide Derivatives, Method for the Preparation and Use Thereof
10/28/2010US20100272677 Heterocyclic antiviral compounds
10/28/2010CA2759821A1 Compositions and methods for treatment of cardiovascular disease
10/28/2010CA2759714A1 Heteroaromatic and aromatic piperazinyl azetidinyl amides as monoacylglycerol lipase inhibitors
10/28/2010CA2759713A1 Azetidinyl diamides as monoacylglycerol lipase inhibitors
10/28/2010CA2759697A1 Azetidinyl diamides as monoacylglycerol lipase inhibitors
10/28/2010CA2759690A1 Carboxylic acid compound
10/28/2010CA2759679A1 Novel compound amycolamicin, method for production thereof, and use thereof
10/28/2010CA2759621A1 Azetidinyl diamides as monoacylglycerol lipase inhibitors
10/28/2010CA2759614A1 Azetidinyl diamides as monoacylglycerol lipase inhibitors
10/28/2010CA2759501A1 Azetidinyl diamides as monoacylglycerol lipase inhibitors
10/28/2010CA2758894A1 Novel thyroid hormone .beta. receptor agonist
10/28/2010CA2758838A1 Heterocyclic antiviral compounds
10/28/2010CA2758210A1 Proline derivatives as cathepsin inhibitors
10/27/2010EP2243776A1 Substituted piperidines and their use for the treatment of diseases related to the histamine H3 receptor
1 ... 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 ... 694